Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Using HIV Risk Assessment Tool to Promote HIV Testing Among Men Who Have Sex With Men (online-RASSL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03320239
Recruitment Status : Recruiting
First Posted : October 25, 2017
Last Update Posted : October 25, 2017
Sponsor:
Information provided by (Responsible Party):
National Center for AIDS/STD Control and Prevention, China CDC

Brief Summary:
The objective of the study is to evaluate the effectiveness of a HIV risk assessment tool to promote HIV testing and to reduce high risk sexual behaviors among men who have sex with men (MSM). It hypothesizes that the social media-based HIV risk assessment tool can increase 20% HIV testing proportion during the six months follow-up period.

Condition or disease Intervention/treatment Phase
HIV/AIDS HIV Infections Social Media Behavioral: HIV risk assessment and tailored suggestions Behavioral: HIV risk behavior assessment Behavioral: placebo control Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 4500 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Prevention
Official Title: Using HIV Risk Assessment Tool to Promote HIV Testing Among Men Who Have Sex With Men in Beijing: a Social Media-based Randomized Trial
Actual Study Start Date : October 12, 2017
Estimated Primary Completion Date : May 2018
Estimated Study Completion Date : May 2018

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: the online-RASSL intervention group
HIV risk assessment and tailored suggestions, free HIV testing link
Behavioral: HIV risk assessment and tailored suggestions
The intervention contains: HIV risk investigation, tailored suggestions and free HIV testing link

Experimental: intervention group 2
HIV risk behavior investigation and routine education
Behavioral: HIV risk behavior assessment
It only contains HIV risk behavior assessment and routine education

Placebo Comparator: the control group
The placebo control: HIV/AIDS knowledge assessment, routine education
Behavioral: placebo control
It only contains HIV/AIDS knowledge assessment and routine education




Primary Outcome Measures :
  1. The proportion of HIV testing during the study period [ Time Frame: 1 month ]
    The numerator is the number of participants who come to the specific HIV testing clinics for HIV test during the study period, the denominator is the number of participants randomized per group.


Secondary Outcome Measures :
  1. unprotected anal intercourse [ Time Frame: 6 months ]
    Questionaire will be used to collect the frequency of unprotected anal intercourse at month 1, month 3 and month 6 after the study starts.

  2. Post exposure prophylaxis (PEP) [ Time Frame: 6 months ]
    Questionaire will be used to collect data on whether participants use PEP at month 1, month 3 and month 6.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Male at birth.
  • Having had homo-sexual behaviors (anal/oral) in the past 6 months before enrollment.
  • An age of 18 years or older.
  • Living in Beijing, China.
  • Self-reporting HIV negative or unknown.
  • Willingly participating into the baseline survey and the six months follow ups.
  • Agreeing not to share the research link to others.
  • Owning a mobile phone and having had downloaded the social networking Application Blued before enrollment.

Exclusion Criteria:

  • Not accepting blood sampling within the study period.
  • Reporting injecting drugs use in the past six months before enrollment.
  • Being currently involved in other HIV behavioral interventions for MSM.
  • Having a specific plan to leave from Beijing in the next 6 months.
  • Self-reporting female.
  • Other reasons the investigators deem make participation either detrimental to the participants or the study.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03320239


Contacts
Layout table for location contacts
Contact: Wu Z You, PhD 010-58900946 wuzy@263.net

Locations
Layout table for location information
China, Beijing
national center for AIDS control and prevention Recruiting
Beijing, Beijing, China, 10026
Contact: Zunyou Wu, PHD    010-58900946    wuzy@263.net   
Sponsors and Collaborators
National Center for AIDS/STD Control and Prevention, China CDC
Investigators
Layout table for investigator information
Study Director: Wu Z You, PhD NATIONAL CENTER FOR HIV/STD CONTROL AND PREVENTION

Layout table for additonal information
Responsible Party: National Center for AIDS/STD Control and Prevention, China CDC
ClinicalTrials.gov Identifier: NCT03320239     History of Changes
Other Study ID Numbers: risk assessment
First Posted: October 25, 2017    Key Record Dates
Last Update Posted: October 25, 2017
Last Verified: October 2017

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by National Center for AIDS/STD Control and Prevention, China CDC:
HIV
risk assessment
HIV testing
unprotected anal intercourse
Social medica

Additional relevant MeSH terms:
Layout table for MeSH terms
HIV Infections
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases